Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet. Psychiatry 2024-06, Vol.11 (6), p.400-402
Hauptverfasser:	Fanshawe, Jack B, Lennox, Belinda R
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - therapeutic use Clozapine - therapeutic use Drug Monitoring - methods Humans Schizophrenia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	402
container_issue	6
container_start_page	400
container_title	The Lancet. Psychiatry
container_volume	11
creator	Fanshawe, Jack B Lennox, Belinda R
description
doi_str_mv	10.1016/S2215-0366(24)00140-8
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3050939047</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2215036624001408</els_id><sourcerecordid>3050939047</sourcerecordid><originalsourceid>FETCH-LOGICAL-c228t-679659b3ad2ac52587d396b7253a1f22fdb669df31e2140138153e4df293534c3</originalsourceid><addsrcrecordid>eNqFkT1vFDEQhi0EIlHITwC5DMWCv3e3ilBIACkSBVBbXnt8Mdq1D9ub6Gj54_hyR1qqGY2e-XpfhF5T8o4Sqt5_Y4zKjnClLph4SwgVpBueodNjuRfPn3KlTtB5KT9Jo7ggshcv0Qkf1NjTfjxFfz4mKLjeAYb74CBawDE94LJuNlAqfgBsTcTFeJh3OINbG7CnfYZfa8N3OHl8Z2AxNc1pE6yZ8ZJiqCmHuME-Zbw1NUCsBZdqpjCHAg6niO2cfpttiHD5Cr3wZi5wfoxn6MfN9ferz93t109frj7cdpaxoXaqH5UcJ24cM1YyOfSOj2rqmeSGesa8m5QanecUWBOE8oFKDsJ5NnLJheVn6OIwd5tTO75UvYRiYZ5NhLQWzYkkIx-J6BsqD6jNqZQMXm9zWEzeaUr03gL9aIHe66uZ0I8W6KH1vTmuWKcF3FPXP8EbcHkAoD16HyDrYsNedhcy2KpdCv9Z8ReQOJbh</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3050939047</pqid></control><display><type>article</type><title>Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine?</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Fanshawe, Jack B ; Lennox, Belinda R</creator><creatorcontrib>Fanshawe, Jack B ; Lennox, Belinda R</creatorcontrib><identifier>ISSN: 2215-0366</identifier><identifier>ISSN: 2215-0374</identifier><identifier>EISSN: 2215-0374</identifier><identifier>DOI: 10.1016/S2215-0366(24)00140-8</identifier><identifier>PMID: 38697179</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antipsychotic Agents - therapeutic use ; Clozapine - therapeutic use ; Drug Monitoring - methods ; Humans ; Schizophrenia - drug therapy</subject><ispartof>The Lancet. Psychiatry, 2024-06, Vol.11 (6), p.400-402</ispartof><rights>2024 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c228t-679659b3ad2ac52587d396b7253a1f22fdb669df31e2140138153e4df293534c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38697179$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fanshawe, Jack B</creatorcontrib><creatorcontrib>Lennox, Belinda R</creatorcontrib><title>Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine?</title><title>The Lancet. Psychiatry</title><addtitle>Lancet Psychiatry</addtitle><subject>Antipsychotic Agents - therapeutic use</subject><subject>Clozapine - therapeutic use</subject><subject>Drug Monitoring - methods</subject><subject>Humans</subject><subject>Schizophrenia - drug therapy</subject><issn>2215-0366</issn><issn>2215-0374</issn><issn>2215-0374</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkT1vFDEQhi0EIlHITwC5DMWCv3e3ilBIACkSBVBbXnt8Mdq1D9ub6Gj54_hyR1qqGY2e-XpfhF5T8o4Sqt5_Y4zKjnClLph4SwgVpBueodNjuRfPn3KlTtB5KT9Jo7ggshcv0Qkf1NjTfjxFfz4mKLjeAYb74CBawDE94LJuNlAqfgBsTcTFeJh3OINbG7CnfYZfa8N3OHl8Z2AxNc1pE6yZ8ZJiqCmHuME-Zbw1NUCsBZdqpjCHAg6niO2cfpttiHD5Cr3wZi5wfoxn6MfN9ferz93t109frj7cdpaxoXaqH5UcJ24cM1YyOfSOj2rqmeSGesa8m5QanecUWBOE8oFKDsJ5NnLJheVn6OIwd5tTO75UvYRiYZ5NhLQWzYkkIx-J6BsqD6jNqZQMXm9zWEzeaUr03gL9aIHe66uZ0I8W6KH1vTmuWKcF3FPXP8EbcHkAoD16HyDrYsNedhcy2KpdCv9Z8ReQOJbh</recordid><startdate>202406</startdate><enddate>202406</enddate><creator>Fanshawe, Jack B</creator><creator>Lennox, Belinda R</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202406</creationdate><title>Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine?</title><author>Fanshawe, Jack B ; Lennox, Belinda R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c228t-679659b3ad2ac52587d396b7253a1f22fdb669df31e2140138153e4df293534c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antipsychotic Agents - therapeutic use</topic><topic>Clozapine - therapeutic use</topic><topic>Drug Monitoring - methods</topic><topic>Humans</topic><topic>Schizophrenia - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fanshawe, Jack B</creatorcontrib><creatorcontrib>Lennox, Belinda R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet. Psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fanshawe, Jack B</au><au>Lennox, Belinda R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine?</atitle><jtitle>The Lancet. Psychiatry</jtitle><addtitle>Lancet Psychiatry</addtitle><date>2024-06</date><risdate>2024</risdate><volume>11</volume><issue>6</issue><spage>400</spage><epage>402</epage><pages>400-402</pages><issn>2215-0366</issn><issn>2215-0374</issn><eissn>2215-0374</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>38697179</pmid><doi>10.1016/S2215-0366(24)00140-8</doi><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 2215-0366
ispartof	The Lancet. Psychiatry, 2024-06, Vol.11 (6), p.400-402
issn	2215-0366 2215-0374 2215-0374
language	eng
recordid	cdi_proquest_miscellaneous_3050939047
source	MEDLINE; Alma/SFX Local Collection
subjects	Antipsychotic Agents - therapeutic use Clozapine - therapeutic use Drug Monitoring - methods Humans Schizophrenia - drug therapy
title	Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine?
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T02%3A02%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Does%20the%20evidence%20now%20suggest%20we%20can%20safely%20reduce%20the%20frequency%20of%20haematological%20monitoring%20for%20patients%20stabilised%20on%20clozapine?&rft.jtitle=The%20Lancet.%20Psychiatry&rft.au=Fanshawe,%20Jack%20B&rft.date=2024-06&rft.volume=11&rft.issue=6&rft.spage=400&rft.epage=402&rft.pages=400-402&rft.issn=2215-0366&rft.eissn=2215-0374&rft_id=info:doi/10.1016/S2215-0366(24)00140-8&rft_dat=%3Cproquest_cross%3E3050939047%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3050939047&rft_id=info:pmid/38697179&rft_els_id=S2215036624001408&rfr_iscdi=true